Allergy - Patients with Atopic Dermatitis Express Themselves Through a Questionnaire.
allergy
atopic dermatitis
patient centricity
Journal
Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
10
2020
accepted:
08
12
2020
entrez:
15
1
2021
pubmed:
16
1
2021
medline:
16
1
2021
Statut:
epublish
Résumé
Allergies are becoming more prevalent across the globe and can be linked to several skin diseases, particularly atopic dermatitis (AD). Disruption of the immune system in the skin can lead to inflammatory diseases such as atopic and contact dermatitis, skin infections, and allergies. This is especially evident in processes such as "atopic march", where in childhood, the development of atopic dermatitis can later lead to food allergies, allergic rhinitis and asthma. The aim of this international online survey is to study the link between self-reported doctor-diagnosed AD and allergy prevalence. Our survey queried a representative sample of the general population over the age of 18 from five countries (Brazil, China, Russia, the USA and France). A total of 9399 participants answered the entire online questionnaire. Among them, 2483 (26.4%) had an allergy diagnosed by a doctor (1243 with food allergies (13.2%), 1564 with respiratory allergies (16.6%) and 1669 with skin allergies (17.7%)). There were 794 (31.9%) participants with current AD in the allergy group and 640 (9.25%) in the group without allergies (p<0.001), and there were 1299 (52.3%) participants with CAD in the allergy group versus 1368 (19.8%) in the group without allergies (p<0.001). Multivariate analysis showed ORs of 3.24 [2.98, 3.63] (p<0.001) for current AD and 2.4 [2.09, 2.74] (p<0.001) for CAD. There was no significant interaction between AD and CAD (p=0.6). A total of 26.4% of survey respondents reported having doctor-diagnosed allergies. Among these patients, half reported having AD during childhood, and 1/3 reported having a current AD. CAD and AD patients clearly have a higher risk of having an allergy than patients without CAD or AD.
Identifiants
pubmed: 33447067
doi: 10.2147/CCID.S285943
pii: 285943
pmc: PMC7802332
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1075-1077Informations de copyright
© 2020 Shourick et al.
Déclaration de conflit d'intérêts
S. Seité is an employee of La Roche-Posay, France. The authors report no other conflicts of interest in this work.
Références
J Clin Cell Immunol. 2014 Apr;5(2):
pubmed: 25419479
J Drugs Dermatol. 2019 Jun 01;18(6):581
pubmed: 31251552
J Investig Allergol Clin Immunol. 2020;30(6):448-450
pubmed: 32376512
Int J Environ Res Public Health. 2020 May 12;17(10):
pubmed: 32408640